{"id":"NCT00529529","sponsor":"Novartis Pharmaceuticals","briefTitle":"Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma","officialTitle":"A 26-week Treatment, Randomized, Multicenter, Double-blind, Double-dummy, Parallel-group Study to Assess the Safety of Indacaterol (300 and 600 µg o.d.) in Patients With Moderate to Severe Persistent Asthma, Using Salmeterol (50 µg b.i.d.) as an Active Control","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-09","primaryCompletion":"2008-08","completion":"2008-08","firstPosted":"2007-09-14","resultsPosted":"2011-08-19","lastUpdate":"2011-08-29"},"enrollment":805,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"Indacaterol 300 μg","otherNames":[]},{"type":"DRUG","name":"Salmeterol 50 μg","otherNames":[]},{"type":"DRUG","name":"Placebo to indacaterol","otherNames":[]},{"type":"DRUG","name":"Placebo to salmeterol","otherNames":[]}],"arms":[{"label":"Indacaterol 300 μg","type":"EXPERIMENTAL"},{"label":"Indacaterol 600 μg","type":"EXPERIMENTAL"},{"label":"Salmeterol 50 μg","type":"ACTIVE_COMPARATOR"}],"summary":"This study was designed to assess the safety of indacaterol (300 µg and 600 µg (2 x 300 μg capsules) once daily \\[od\\]), compared with salmeterol (50 μg twice a day \\[b.i.d.\\]), over 26 weeks, in patients with moderate to severe persistent asthma.","primaryOutcome":{"measure":"Percentage of Patients With at Least 1 Adverse Event During the 26 Weeks of the Study","timeFrame":"Baseline (Day 1) to end of study (Week 26)","effectByArm":[{"arm":"Indacaterol 300 μg","deltaMin":54.9,"sd":null},{"arm":"Indacaterol 600 μg","deltaMin":66.4,"sd":null},{"arm":"Salmeterol 50 μg","deltaMin":67.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":126,"countries":["United States","Argentina","Canada","Czechia","France","Germany","Hungary","Italy","Peru","Slovakia","Spain","Turkey (Türkiye)"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":268},"commonTop":["Asthma","Cough","Nasopharyngitis","Upper respiratory tract infection","Headache"]}}